Logo image of ALMKT.PA

MAUNA KEA TECHNOLOGIES (ALMKT.PA) Stock Fundamental Analysis

EPA:ALMKT - Euronext Paris - Matif - FR0010609263 - Common Stock - Currency: EUR

0.1756  +0 (+0.34%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALMKT. ALMKT was compared to 55 industry peers in the Health Care Equipment & Supplies industry. ALMKT has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ALMKT is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALMKT has reported negative net income.
ALMKT had a negative operating cash flow in the past year.
In the past 5 years ALMKT always reported negative net income.
In the past 5 years ALMKT always reported negative operating cash flow.
ALMKT.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M

1.2 Ratios

ALMKT's Return On Assets of -20.54% is on the low side compared to the rest of the industry. ALMKT is outperformed by 69.09% of its industry peers.
ALMKT has a better Return On Invested Capital (13.46%) than 92.73% of its industry peers.
Industry RankSector Rank
ROA -20.54%
ROE N/A
ROIC 13.46%
ROA(3y)-42.36%
ROA(5y)-50.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMKT.PA Yearly ROA, ROE, ROICALMKT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K

1.3 Margins

With a decent Operating Margin value of 11.75%, ALMKT is doing good in the industry, outperforming 67.27% of the companies in the same industry.
ALMKT's Gross Margin of 33.62% is on the low side compared to the rest of the industry. ALMKT is outperformed by 78.18% of its industry peers.
Industry RankSector Rank
OM 11.75%
PM (TTM) N/A
GM 33.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALMKT.PA Yearly Profit, Operating, Gross MarginsALMKT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150 -200

More info and screens

1

2. Health

2.1 Basic Checks

ALMKT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
ALMKT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ALMKT has been increased compared to 5 years ago.
ALMKT has a better debt/assets ratio than last year.
ALMKT.PA Yearly Shares OutstandingALMKT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
ALMKT.PA Yearly Total Debt VS Total AssetsALMKT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

ALMKT has an Altman-Z score of -1.46. This is a bad value and indicates that ALMKT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.46, ALMKT is doing worse than 74.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.46
ROIC/WACC2.23
WACC6.04%
ALMKT.PA Yearly LT Debt VS Equity VS FCFALMKT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

A Current Ratio of 0.94 indicates that ALMKT may have some problems paying its short term obligations.
ALMKT's Current ratio of 0.94 is on the low side compared to the rest of the industry. ALMKT is outperformed by 80.00% of its industry peers.
A Quick Ratio of 0.66 indicates that ALMKT may have some problems paying its short term obligations.
The Quick ratio of ALMKT (0.66) is worse than 65.45% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.66
ALMKT.PA Yearly Current Assets VS Current LiabilitesALMKT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 69.76% over the past year.
ALMKT shows a strong growth in Revenue. In the last year, the Revenue has grown by 40.11%.
Measured over the past years, ALMKT shows a quite strong growth in Revenue. The Revenue has been growing by 9.16% on average per year.
EPS 1Y (TTM)69.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-250.72%
Revenue 1Y (TTM)40.11%
Revenue growth 3Y17.08%
Revenue growth 5Y9.16%
Sales Q2Q%-43.2%

3.2 Future

ALMKT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.11% yearly.
The Revenue is expected to grow by 13.60% on average over the next years. This is quite good.
EPS Next Y56.52%
EPS Next 2Y25.11%
EPS Next 3Y16.11%
EPS Next 5YN/A
Revenue Next Year-20.42%
Revenue Next 2Y2.84%
Revenue Next 3Y13.6%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALMKT.PA Yearly Revenue VS EstimatesALMKT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M
ALMKT.PA Yearly EPS VS EstimatesALMKT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALMKT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALMKT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALMKT.PA Price Earnings VS Forward Price EarningsALMKT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

83.64% of the companies in the same industry are more expensive than ALMKT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.23
ALMKT.PA Per share dataALMKT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 -0.2 -0.3

4.3 Compensation for Growth

A more expensive valuation may be justified as ALMKT's earnings are expected to grow with 16.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.11%
EPS Next 3Y16.11%

More info and screens

0

5. Dividend

5.1 Amount

ALMKT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAUNA KEA TECHNOLOGIES

EPA:ALMKT (3/7/2025, 7:00:00 PM)

0.1756

+0 (+0.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-30 2024-10-30
Earnings (Next)04-24 2025-04-24/amc
Inst Owners16.8%
Inst Owner ChangeN/A
Ins Owners0.91%
Ins Owner ChangeN/A
Market Cap11.36M
Analysts86.67
Price Target0.82 (366.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-28.97%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.08
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 12.23
EPS(TTM)-0.08
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.11
OCFYN/A
SpS0.16
BVpS-0.31
TBVpS-0.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.54%
ROE N/A
ROCE 18.32%
ROIC 13.46%
ROICexc 31.17%
ROICexgc 77.27%
OM 11.75%
PM (TTM) N/A
GM 33.62%
FCFM N/A
ROA(3y)-42.36%
ROA(5y)-50.76%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 10.24
Cap/Depr 23.09%
Cap/Sales 3.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.66
Altman-Z -1.46
F-Score1
WACC6.04%
ROIC/WACC2.23
Cap/Depr(3y)29.78%
Cap/Depr(5y)57.62%
Cap/Sales(3y)6.6%
Cap/Sales(5y)10.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-250.72%
EPS Next Y56.52%
EPS Next 2Y25.11%
EPS Next 3Y16.11%
EPS Next 5YN/A
Revenue 1Y (TTM)40.11%
Revenue growth 3Y17.08%
Revenue growth 5Y9.16%
Sales Q2Q%-43.2%
Revenue Next Year-20.42%
Revenue Next 2Y2.84%
Revenue Next 3Y13.6%
Revenue Next 5YN/A
EBIT growth 1Y113.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y30.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.24%
OCF growth 3YN/A
OCF growth 5YN/A